US HB1051 | 2025-2026 | 119th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 6 2025 - 25% progression
Action: 2025-02-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Status: Introduced on February 6 2025 - 25% progression
Action: 2025-02-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Summary
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Title
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Sponsors
| Rep. Nikki Budzinski [D-IL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2025-02-06 | House | Referred to the House Committee on Energy and Commerce. |
| 2025-02-06 | House | Introduced in House |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/house-bill/1051/all-info |
